• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

23andME Partners w/Genetech for Parkinson's Disease Research

W

Wally

Senior Member
Messages
1,167
Personal genetics-testing startup 23andMe is teaming up with Genentech to try to identify new treatments for Parkinson’s disease . . . . Under the deal, Genentech will sequence the whole genomes of about 3,000 people with Parkinson’s disease in 23andMe’s database, and use that data to look for new therapeutic targets that could treat the neurodegenerative condition.
Click here to read the article - http://www.sfgate.com/health/article/23andMe-and-Genentech-in-deal-to-research-5997703.php
Click to expand...
Click to expand...
 
You must log in or register to reply here.